These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33377106)
1. High-throughput drug screening of fine-needle aspiration-derived cancer organoids. Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106 [TBL] [Abstract][Full Text] [Related]
2. Immunofluorescent staining of cancer spheroids and fine-needle aspiration-derived organoids. Bergdorf KN; Phifer CJ; Bechard ME; Lee MA; McDonald OG; Lee E; Weiss VL STAR Protoc; 2021 Jun; 2(2):100578. PubMed ID: 34136836 [TBL] [Abstract][Full Text] [Related]
3. Obtaining patient-derived cancer organoid cultures via fine-needle aspiration. Phifer CJ; Bergdorf KN; Bechard ME; Vilgelm A; Baregamian N; McDonald OG; Lee E; Weiss VL STAR Protoc; 2021 Mar; 2(1):100220. PubMed ID: 33377121 [TBL] [Abstract][Full Text] [Related]
4. Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening. Nguyen HTL; Soragni A STAR Protoc; 2020 Sep; 1(2):. PubMed ID: 33043307 [TBL] [Abstract][Full Text] [Related]
5. Establishment of patient-derived cancer organoids for drug-screening applications. Driehuis E; Kretzschmar K; Clevers H Nat Protoc; 2020 Oct; 15(10):3380-3409. PubMed ID: 32929210 [TBL] [Abstract][Full Text] [Related]
6. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids. Tan T; Mouradov D; Gibbs P; Sieber OM STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757 [TBL] [Abstract][Full Text] [Related]
7. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening. Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871 [TBL] [Abstract][Full Text] [Related]
8. Functional assays with human patient-derived enteroid monolayers to assess the human gut barrier. Sayed IM; Tindle C; Fonseca AG; Ghosh P; Das S STAR Protoc; 2021 Sep; 2(3):100680. PubMed ID: 34337445 [TBL] [Abstract][Full Text] [Related]
9. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening. Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727 [TBL] [Abstract][Full Text] [Related]
11. Normal and tumor-derived organoids as a drug screening platform for tumor-specific drug vulnerabilities. Calandrini C; Drost J STAR Protoc; 2022 Mar; 3(1):101079. PubMed ID: 35036959 [TBL] [Abstract][Full Text] [Related]
12. Protocol for the generation of cultured cortical brain organoid slices. Petersilie L; Kafitz KW; Neu LA; Heiduschka S; Le S; Prigione A; Rose CR STAR Protoc; 2024 Sep; 5(3):103212. PubMed ID: 39128007 [TBL] [Abstract][Full Text] [Related]
13. Establishment and Long-Term Culture of Organoids Derived from Human Biliary Tract Carcinoma. Saito Y; Muramatsu T; Saito H STAR Protoc; 2020 Jun; 1(1):100009. PubMed ID: 33111070 [TBL] [Abstract][Full Text] [Related]
14. Generation of Pancreatic Organoid-Derived Isografts. D'Agosto S; Lupo F; Corbo V STAR Protoc; 2020 Sep; 1(2):100047. PubMed ID: 33111093 [TBL] [Abstract][Full Text] [Related]
15. Protocol for establishing organoids from human ovarian cancer biopsies. Maenhoudt N; Vankelecom H STAR Protoc; 2021 Jun; 2(2):100429. PubMed ID: 33870230 [TBL] [Abstract][Full Text] [Related]
16. Drug screening by uniform patient derived colorectal cancer hydro-organoids. Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688 [TBL] [Abstract][Full Text] [Related]
17. Protocol for Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells. Sander V; Przepiorski A; Crunk AE; Hukriede NA; Holm TM; Davidson AJ STAR Protoc; 2020 Dec; 1(3):100150. PubMed ID: 33377044 [TBL] [Abstract][Full Text] [Related]
18. Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging. Larsen BM; Cancino A; Shaxted JM; Salahudeen AA STAR Protoc; 2022 Jun; 3(2):101407. PubMed ID: 35620075 [TBL] [Abstract][Full Text] [Related]
19. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures. Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291 [TBL] [Abstract][Full Text] [Related]
20. High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing. Jun HR; Kang HJ; Ju SH; Kim JE; Jeon SY; Ku B; Lee JJ; Kim M; Kim MJ; Choi JJ; Noh JJ; Kim HS; Lee JW; Lee JK; Lee DW Biomaterials; 2023 May; 296():122087. PubMed ID: 36924663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]